vs
Assertio Holdings, Inc.（ASRT）与1stdibs.com, Inc.（DIBS）财务数据对比。点击上方公司名可切换其他公司
1stdibs.com, Inc.的季度营收约是Assertio Holdings, Inc.的1.7倍（$23.0M vs $13.5M），1stdibs.com, Inc.同比增速更快（0.9% vs -57.9%），过去两年1stdibs.com, Inc.的营收复合增速更高（2.0% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
1stdibs.com, Inc.是一家美国电商企业，运营线上奢侈品交易平台，主营室内设计高端家具、艺术藏品、珠宝等高端商品。品牌最初创立于巴黎，现总部设于纽约，凭借推动古董行业迈入21世纪的创新举措获得业内认可。
ASRT vs DIBS — 直观对比
营收规模更大
DIBS
是对方的1.7倍
$13.5M
营收增速更快
DIBS
高出58.8%
-57.9%
两年增速更快
DIBS
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $23.0M |
| 净利润 | — | $-1.0M |
| 毛利率 | — | 73.5% |
| 营业利润率 | -86.7% | -10.1% |
| 净利率 | — | -4.5% |
| 营收同比 | -57.9% | 0.9% |
| 净利润同比 | — | 80.0% |
| 每股收益（稀释后） | $-4.54 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTDIBS
| Q4 25 | $13.5M | $23.0M | ||
| Q3 25 | $49.5M | $22.0M | ||
| Q2 25 | $29.2M | $22.1M | ||
| Q1 25 | $26.5M | $22.5M | ||
| Q4 24 | $32.2M | $22.8M | ||
| Q3 24 | $29.2M | $21.2M | ||
| Q2 24 | $31.1M | $22.2M | ||
| Q1 24 | $32.4M | $22.1M |
净利润ASRTDIBS
| Q4 25 | — | $-1.0M | ||
| Q3 25 | $11.4M | $-3.5M | ||
| Q2 25 | $-16.4M | $-4.3M | ||
| Q1 25 | $-13.5M | $-4.8M | ||
| Q4 24 | — | $-5.2M | ||
| Q3 24 | $-2.9M | $-5.7M | ||
| Q2 24 | $-3.7M | $-4.4M | ||
| Q1 24 | $-4.5M | $-3.3M |
毛利率ASRTDIBS
| Q4 25 | — | 73.5% | ||
| Q3 25 | — | 74.3% | ||
| Q2 25 | — | 71.8% | ||
| Q1 25 | — | 72.4% | ||
| Q4 24 | — | 72.3% | ||
| Q3 24 | — | 71.0% | ||
| Q2 24 | — | 71.7% | ||
| Q1 24 | — | 72.5% |
营业利润率ASRTDIBS
| Q4 25 | -86.7% | -10.1% | ||
| Q3 25 | 23.2% | -21.3% | ||
| Q2 25 | -27.5% | -25.8% | ||
| Q1 25 | -50.0% | -27.7% | ||
| Q4 24 | -41.9% | -30.6% | ||
| Q3 24 | -10.4% | -34.9% | ||
| Q2 24 | -11.6% | -29.2% | ||
| Q1 24 | -13.4% | -24.3% |
净利率ASRTDIBS
| Q4 25 | — | -4.5% | ||
| Q3 25 | 23.1% | -16.0% | ||
| Q2 25 | -56.0% | -19.5% | ||
| Q1 25 | -51.1% | -21.3% | ||
| Q4 24 | — | -22.9% | ||
| Q3 24 | -10.0% | -26.8% | ||
| Q2 24 | -11.8% | -20.0% | ||
| Q1 24 | -13.9% | -15.0% |
每股收益（稀释后）ASRTDIBS
| Q4 25 | $-4.54 | $-0.02 | ||
| Q3 25 | $0.11 | $-0.10 | ||
| Q2 25 | $-0.17 | $-0.12 | ||
| Q1 25 | $-0.14 | $-0.14 | ||
| Q4 24 | $-3.28 | $-0.14 | ||
| Q3 24 | $-0.03 | $-0.15 | ||
| Q2 24 | $-0.04 | $-0.12 | ||
| Q1 24 | $-0.05 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $22.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $93.6M |
| 总资产 | $267.0M | $132.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTDIBS
| Q4 25 | $63.4M | $22.9M | ||
| Q3 25 | $93.4M | $19.9M | ||
| Q2 25 | $98.2M | $22.4M | ||
| Q1 25 | $87.3M | $20.3M | ||
| Q4 24 | $100.1M | $26.0M | ||
| Q3 24 | $88.6M | $22.0M | ||
| Q2 24 | $88.4M | $23.8M | ||
| Q1 24 | $80.7M | $33.7M |
总债务ASRTDIBS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTDIBS
| Q4 25 | $94.0M | $93.6M | ||
| Q3 25 | $105.8M | $94.0M | ||
| Q2 25 | $93.3M | $94.9M | ||
| Q1 25 | $108.5M | $96.2M | ||
| Q4 24 | $121.1M | $99.3M | ||
| Q3 24 | $130.5M | $107.2M | ||
| Q2 24 | $132.2M | $110.4M | ||
| Q1 24 | $134.5M | $131.0M |
总资产ASRTDIBS
| Q4 25 | $267.0M | $132.1M | ||
| Q3 25 | $319.8M | $135.2M | ||
| Q2 25 | $273.8M | $138.6M | ||
| Q1 25 | $286.4M | $142.5M | ||
| Q4 24 | $284.7M | $145.8M | ||
| Q3 24 | $276.0M | $154.4M | ||
| Q2 24 | $279.4M | $157.6M | ||
| Q1 24 | $282.0M | $179.5M |
负债/权益比ASRTDIBS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | — | $3.6M |
| 自由现金流率自由现金流/营收 | — | 15.7% |
| 资本支出强度资本支出/营收 | — | 2.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-3.2M |
8季度趋势，按日历期对齐
经营现金流ASRTDIBS
| Q4 25 | $-30.0M | $4.3M | ||
| Q3 25 | $-4.8M | $-1.5M | ||
| Q2 25 | $19.1M | $-5.1M | ||
| Q1 25 | $-12.5M | $-96.0K | ||
| Q4 24 | $11.5M | $2.8M | ||
| Q3 24 | $-35.0K | $-3.0K | ||
| Q2 24 | $7.4M | $-2.6M | ||
| Q1 24 | $7.5M | $-3.1M |
自由现金流ASRTDIBS
| Q4 25 | — | $3.6M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $-5.2M | ||
| Q1 25 | — | $-143.0K | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | — | $-44.0K | ||
| Q2 24 | — | $-3.0M | ||
| Q1 24 | — | $-3.3M |
自由现金流率ASRTDIBS
| Q4 25 | — | 15.7% | ||
| Q3 25 | — | -6.8% | ||
| Q2 25 | — | -23.4% | ||
| Q1 25 | — | -0.6% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | -0.2% | ||
| Q2 24 | — | -13.5% | ||
| Q1 24 | — | -14.8% |
资本支出强度ASRTDIBS
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 0.9% |
现金转化率ASRTDIBS
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
DIBS
暂无分部数据
